ANZCTR search results

These search results are from the Australian New Zealand Clinical Trials Registry (ANZCTR).

You can narrow down the results using the filters

32704 results sorted by trial registration date.
  • A randomised controlled trial to reduce further falls and injuries for older fallers presenting to an Emergency Department.

  • Performance Evaluation of the GIVEN Patency System

  • Evaluation of the PillCam ESO Capsule in the Detection of Esophageal Varices

  • Evaluation of Cognitive Behavioural Therapy programme for insomnia

  • Efficacy of 8 weeks open label aripiprazole as augmentation therapy in Bipolar II disorder

    Study approved

  • A multi-centre, randomised, controlled trial of bronchoalveolar lavage (BAL) directed therapy in young children with cystic fibrosis (CF).

    1. This study will examine the use and safety of FB and BAL to identify lower respiratory tract infection (especially PA) in infants and young children with CF and direct therapy in an attempt to eradicate proven early lung infection. 2. The role of infection and inflammation in the development of CF lung disease will be examined in a large cohort of CF infants recruited prospectively and followed longitudinally.

  • Mechanisms of Action of an ATTORI Celery Seed Extract in Osteoarthritis

  • Pravastatin for Hyperlipidaemia in HIV.

    This study is a randomised, placebo-controlled study of the effect of treatment with the HMG-CoA reductase inhibitor, pravastatin, in HIV-infected, protease inhibitor treated patients with high serum cholesterol. We hypothesise that pravastatin will result in greater reductions in cholesterol than placebo when used in conjunction with appropriate dietary advice.

  • HIV Infection And Metabolic Abnormalities Protocol 1 (HAMA 001)

    A prospective, non-randomised, 48 week study of the effect of PI containing and non-PI containing antiretroviral regimens on the expression of adipocyte specific genes, protein levels and cellular structure in HIV-infected individuals, naive to therapy, who are starting therapy for the first time.

  • Seronegatives And Metabolic Abnormalities Protocol 2 (SAMA 002)

    A randomised study of the effect of treatment with Combivir (zidovudine [AZT] and lamivudine [3TC]) and Kaletra (lopinavir [LPVr]), alone and in combination, on the development of abnormalities in lipid and glucose metabolism in HIV negative healthy subjects

Tags:
  • Finding clinical trials